JR
Jitendrapratap Rambahadur Singh
About Jitendrapratap Rambahadur Singh
Data last updated:
Jitendrapratap Rambahadur Singh is a Whole-Time Director at Brooks Laboratories Limited (since 2022) and Whole-Time Director at Abridge Speciality Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Brooks Laboratories Limited at ₹83.44 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 23 Nov 2022 | 2002 | ₹83.44 Cr (FY 2025) | Active | |
| Whole-Time Director | 02 Jul 2026 | 2026 | Active |
Board colleagues of Jitendrapratap Rambahadur Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jitendrapratap Rambahadur Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jitendrapratap Rambahadur Singh
Jitendrapratap Rambahadur Singh currently holds 2 directorships: Brooks Laboratories Limited (Whole-Time Director, since 23 Nov 2022, revenue ₹83.44 Cr (FY 2025)); Abridge Speciality Limited (Whole-Time Director, since 02 Jul 2026).
Jitendrapratap Rambahadur Singh was first appointed on 23 Nov 2022 as Whole-Time Director at Brooks Laboratories Limited. The most recent appointment on record is 02 Jul 2026 at Abridge Speciality Limited.
The current boards of Jitendrapratap Rambahadur Singh's companies include Bhushan Singh Rana (Brooks Laboratories Limited), Durga Shankar Maity (Brooks Laboratories Limited), Krutika Mohan Rane (Brooks Laboratories Limited), Lalit Mahajan (Brooks Laboratories Limited), Manav Mahajan (Brooks Laboratories Limited), Prashant Rathi (Brooks Laboratories Limited), among others.